LINDSAY YODER: Open Payments
NPI 1184918161 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,415 in 42 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $1,384 · 2025 $19,415
Speaker / faculty: $7,965Consulting: $6,088Travel & lodging: $2,995Food & beverage: $1,575Honoraria: $760Education: $32
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $8,532 |
| Gilead Sciences, Inc. | 19 | $7,043 |
| Ipsen Biopharmaceuticals, Inc | 4 | $2,749 |
| Novo Nordisk Inc | 4 | $1,063 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: REZDIFFRA, Livdelzi, IQIRVO, Wegovy, DIFICID.
Industry payments across IN — which companies pay providers there.
